BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
BioWorld 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, December 27, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 2, 1998
View Archived Issues
Diane-35 now available in Canada for treatment of acne
Read More
U.S. patent issued for Maxim's MaxVax technology
Read More
LIPID study establishes efficacy of pravastatin in patients with lower cholesterol levels
Read More
Vical provides clinical update of Leuvectin in treatment of prostate cancer
Read More
Mechanism-of-action studies of nifekalant described
Read More
Improved antibacterial efficacy observed with OPC-20011
Read More
Microbix and Gensia Sicor terminate licensing agreement
Read More
Sonus and Daiichi terminate licensing agreement
Read More
AMBI seeks partners to develop oral nisin for H. pylori eradication
Read More
FDA approves new indications, dosing regimens for Vantin
Read More
Health Canada approves lamivudine for treatment of chronic HBV
Read More
CPMP issues positive opinion for E.U. approval of Zenapax
Read More
Pfizer announces further product launches for novel quinolone
Read More
Preclinical study results indicate feasibility of long-term administration of antihypertensive drug
Read More
Inhibitors of neovascularization (angiogenesis) patented by JT
Read More
Taisho discloses new antitumor series
Read More
Gene therapies for neuromuscular diseases pursued by Transgene and AFM
Read More
U.K. approval for new controlled-release nifedipine based on TIMERx technology
Read More
Albuterol delivered by novel MSI system enters clinical evaluation
Read More
Lead SelCID compound poised to enter phase II clinical trials for Crohn's disease
Read More
Novel injectable drug delivery technology in-licensed by Medi-Ject
Read More
Isis sublicenses technology for designing improved antisense drugs
Read More
Additional dose of 5G1.1-SC for phase IIb CPB study identified in phase I trial
Read More
Clinical anti-HIV activity of FTC correlated with intracellular levels of triphosphate
Read More
Hydroxyurea-containing salvage regimens for advanced-stage HIV infection
Read More
Lack of cardiotoxicity of SM-5887 confirmed in dogs
Read More
Advisory committee recommends approval of Celebrex for arthritis and further discussions for pain
Read More
Comparison of LT and TxA2 antagonists in asthmatic patients
Read More